Legal & General Group
ALMR

Legal & General Group’s Alamar Biosciences ALMR Stock Holding History

Legal & General Group’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35K Buy
+1,292
New +$29.2K ﹤0.01% 2895

Other funds holding ALMR

SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Legal & General Group's ALMR Position: Q2 2026 in Review

Legal & General Group opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 1,292 shares worth $35K. The stake represents ﹤0.01% of the portfolio and ranks #2895 among its holdings.

86 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • Legal & General Group held 1,292 shares of Alamar Biosciences worth $35K as of Q2 2026.
  • Alamar Biosciences was a new Legal & General Group position in Q2 2026.
  • Alamar Biosciences made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2895 holding.
  • 86 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.